Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

670820

Sigma-Aldrich

Pam3-Cys-OH

≥98.0% (TLC)

Synonym(e):

N-α-Palmitoyl-S-[2,3-bis-(palmitoyloxy)-(2RS)-propyl]-L-cystein, Palmitoyl-Cys-[(RS)-2,3-di-(palmitoyloxy)-propyl]-OH

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C54H103NO7S
CAS-Nummer:
87420-41-5
Molekulargewicht:
910.46
MDL-Nummer:
MFCD00153468
UNSPSC-Code:
12352200
eCl@ss:
32160406
PubChem Substanz-ID:
24885087
NACRES:
NA.22

Qualitätsniveau

100

Assay

≥98.0% (TLC)

Eignung der Reaktion

reaction type: solution phase peptide synthesis

Anwendung(en)

peptide synthesis

SMILES String

CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(O)=O

InChI

1S/C54H103NO7S/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-51(56)55-50(54(59)60)48-63-47-49(62-53(58)45-42-39-36-33-30-27-24-21-18-15-12-9-6-3)46-61-52(57)44-41-38-35-32-29-26-23-20-17-14-11-8-5-2/h49-50H,4-48H2,1-3H3,(H,55,56)(H,59,60)/t49?,50-/m0/s1

InChIKey

PZFZLRNAOHUQPH-GOOVXGPGSA-N

Verwandte Kategorien

Allgemeine Beschreibung

Pam3-Cys-OH is a lipopeptide containing a cysteine residue at the C-terminus, often used in solid phase peptide synthesis.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 6

1 of 6

L-α-Phosphatidylethanolamin, Dioleoyl ≥99% (GC), ≥98% (TLC), lyophilized powder

Sigma-Aldrich

P1223

L-α-Phosphatidylethanolamin, Dioleoyl

β-D-Glucan aus Gerste ≥95% (HPLC)

Sigma-Aldrich

G6513

β-D-Glucan aus Gerste

Phorbol-12-myristat-13-acetat ≥99% (TLC), film or powder

Sigma-Aldrich

P8139

Phorbol-12-myristat-13-acetat

Sigma-Aldrich

Sigma-Aldrich

A-003-M

Poly-D-Lysin-Lösung, 1,0 mg/ml

Ionomycin Calciumsalz aus Streptomyces conglobatus powder, ≥98% (HPLC)

Sigma-Aldrich

I0634

Ionomycin Calciumsalz aus Streptomyces conglobatus

Sigma-Aldrich

Sigma-Aldrich

SRE0027

Heparin Natriumsalz aus Schweinedarm

Pitchaimani Kandasamy et al.
The Journal of biological chemistry, 286(10), 7841-7853 (2011-01-06)
Mycoplasma pneumoniae is a human pathogen causing respiratory infections that are also associated with serious exacerbations of chronic lung diseases. Membranes and lipoproteins from M. pneumoniae induced a 4-fold increase in arachidonic acid (AA) release from RAW264.7 and a 2-fold
Sudha Natarajan et al.
Shock (Augusta, Ga.), 33(2), 162-169 (2009-06-03)
LPS challenge causes potent activation of innate immunity. Because LPS is ubiquitously present in ambient air, repeated inhalation may lead to activation of the pulmonary immune response. If this activation is unregulated, chronic LPS inhalation would lead to persistent inflammation
Katharina A Remer et al.
Journal of immunological methods, 313(1-2), 1-10 (2006-05-25)
THP-1 2A9, a subclone of the monocytoid cell line THP-1 and known to be exquisitely sensitive to LPS, was tested for TNF production following triggering by excess doses of TLR ligands. TLR2, TLR4 and TLR5 agonists, but neither TLR3 nor
Amrita D Joshi et al.
Journal of leukocyte biology, 83(2), 314-324 (2007-11-22)
Macrophages play a pivotal role in innate and acquired immune responses to Schistosoma mansoni. Classical (M1) or alternative (M2) activation states of these cells further delineate their roles in tissue damage through innate immunity or fibrotic remodeling, respectively. In the
Peter M Moyle et al.
Current medicinal chemistry, 15(5), 506-516 (2008-02-22)
Despite the important role of adjuvants for vaccine development, relatively few adjuvants have been successfully incorporated into vaccines intended for human administration. This is in part due to the high toxicity associated with many experimental adjuvants. This lack of choice
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.